David M. Epstein
Net Worth
Last updated:
What is David M. Epstein net worth?
The estimated net worth of Dr. David M. Epstein is at least $8,030,911 as of 27 Jun 2023. He owns shares worth $1,772,557 as insider, has earned $2,069,404 from insider trading and has received compensation worth at least $4,188,950 in Black Diamond Therapeutics, Inc..
What is the salary of David M. Epstein?
Dr. David M. Epstein salary is $837,790 per year as Co-Founder, Pres, Chief Executive Officer & Director in Black Diamond Therapeutics, Inc..
How old is David M. Epstein?
Dr. David M. Epstein is 66 years old, born in 1959.
What stocks does David M. Epstein currently own?
As insider, Dr. David M. Epstein owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | Co-Founder, Pres, Chief Executive Officer & Director | 671,423 | $2.64 | $1,772,557 |
What does Black Diamond Therapeutics, Inc. do?
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
David M. Epstein insider trading
Black Diamond Therapeutics, Inc.
Dr. David M. Epstein has made 7 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of BDTX stock worth $167,500 on 27 Jun 2023.
The largest trade he's ever made was exercising 25,000 units of BDTX stock on 27 Jun 2023. As of 27 Jun 2023 he still owns at least 671,423 units of BDTX stock.
Black Diamond Therapeutics key executives
Black Diamond Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. David M. Epstein (66) Co-Founder, Pres, Chief Executive Officer & Director
- Dr. Rachel Wallach Humphrey M.D., Ph.D. (64) Advisor
- Mr. Brent Hatzis-Schoch Esq., J.D. (60) Chief Operating Officer & Gen. Counsel